메뉴 건너뛰기




Volumn 69, Issue 2, 2007, Pages 245-250

Radical Hypofractionated Accelerated Radiotherapy with Cytoprotection for Invasive Bladder Cancer

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; ANTINEOPLASTIC AGENT; DOXORUBICIN;

EID: 33847011800     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.09.064     Document Type: Article
Times cited : (9)

References (30)
  • 1
    • 0037099683 scopus 로고    scopus 로고
    • Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results
    • Rodel C., Grabenbauer G.G., Kuhn R., et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20 (2002) 3061-3071
    • (2002) J Clin Oncol , vol.20 , pp. 3061-3071
    • Rodel, C.1    Grabenbauer, G.G.2    Kuhn, R.3
  • 2
    • 0031985484 scopus 로고    scopus 로고
    • Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer
    • Sauer R., Birkenhake S., Kuhn R., et al. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys 40 (1998) 121-127
    • (1998) Int J Radiat Oncol Biol Phys , vol.40 , pp. 121-127
    • Sauer, R.1    Birkenhake, S.2    Kuhn, R.3
  • 3
    • 0025912878 scopus 로고
    • Dose fractionation and tumour repopulation in radiotherapy for bladder cancer
    • Maciejewski B., and Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother Oncol 21 (1991) 163-170
    • (1991) Radiother Oncol , vol.21 , pp. 163-170
    • Maciejewski, B.1    Majewski, S.2
  • 5
    • 0031785195 scopus 로고    scopus 로고
    • Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control
    • Moonen L., van der Voet H., de Nijs R., et al. Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control. Int J Radiat Oncol Biol Phys 42 (1998) 525-530
    • (1998) Int J Radiat Oncol Biol Phys , vol.42 , pp. 525-530
    • Moonen, L.1    van der Voet, H.2    de Nijs, R.3
  • 6
    • 18144406138 scopus 로고    scopus 로고
    • A randomised trial of accelerated radiotherapy for localised invasive bladder cancer
    • Horwich A., Dearnaley D., Huddart R., et al. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer. Radiother Oncol 75 (2005) 34-43
    • (2005) Radiother Oncol , vol.75 , pp. 34-43
    • Horwich, A.1    Dearnaley, D.2    Huddart, R.3
  • 7
    • 0030949541 scopus 로고    scopus 로고
    • Hypofractionated radiotherapy for invasive bladder cancer
    • Scholten A.N., Leer J.W., Collins C.D., et al. Hypofractionated radiotherapy for invasive bladder cancer. Radiother Oncol 43 (1997) 163-169
    • (1997) Radiother Oncol , vol.43 , pp. 163-169
    • Scholten, A.N.1    Leer, J.W.2    Collins, C.D.3
  • 8
    • 0032727504 scopus 로고    scopus 로고
    • Hypofractionated radiotherapy for patients with carcinoma of the bladder
    • Jose C.C., Price A., Norman A., et al. Hypofractionated radiotherapy for patients with carcinoma of the bladder. Clin Oncol 11 (1999) 330-333
    • (1999) Clin Oncol , vol.11 , pp. 330-333
    • Jose, C.C.1    Price, A.2    Norman, A.3
  • 9
    • 0033663646 scopus 로고    scopus 로고
    • The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response
    • Kaufman D.S., Winter K.A., Shipley W.U., et al. The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response. Oncologist 5 (2000) 471-476
    • (2000) Oncologist , vol.5 , pp. 471-476
    • Kaufman, D.S.1    Winter, K.A.2    Shipley, W.U.3
  • 10
    • 33644510453 scopus 로고    scopus 로고
    • Radical radiotherapy for invasive bladder cancer: what dose and fractionation schedule to choose?
    • Pos F.J., Hart G., Schneider C., et al. Radical radiotherapy for invasive bladder cancer: what dose and fractionation schedule to choose?. Int J Radiat Oncol Biol Phys 64 (2006) 1168-1173
    • (2006) Int J Radiat Oncol Biol Phys , vol.64 , pp. 1168-1173
    • Pos, F.J.1    Hart, G.2    Schneider, C.3
  • 11
    • 6344226304 scopus 로고    scopus 로고
    • Conformal hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC) for high risk prostatic carcinoma: rationale, technique and early experience
    • Koukourakis M.I., Touloupidis S., Manavis J., et al. Conformal hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC) for high risk prostatic carcinoma: rationale, technique and early experience. Anticancer Res 24 (2004) 3239-3243
    • (2004) Anticancer Res , vol.24 , pp. 3239-3243
    • Koukourakis, M.I.1    Touloupidis, S.2    Manavis, J.3
  • 12
    • 0036137527 scopus 로고    scopus 로고
    • Tumor and Angiogenesis Research Group: Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients
    • Koukourakis M.I., Giatromanolaki A., Kouroussis C., et al. Tumor and Angiogenesis Research Group: Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients. Int J Radiat Oncol Biol Phys 52 (2002) 144-155
    • (2002) Int J Radiat Oncol Biol Phys , vol.52 , pp. 144-155
    • Koukourakis, M.I.1    Giatromanolaki, A.2    Kouroussis, C.3
  • 13
    • 0030827548 scopus 로고    scopus 로고
    • The biodistribution and pharmacokinetics of stealth liposomes in patients with solid tumors
    • Stewart S., and Harrington K.J. The biodistribution and pharmacokinetics of stealth liposomes in patients with solid tumors. Oncology 11 suppl 11 (1997) 33-36
    • (1997) Oncology , vol.11 , Issue.SUPPL. 11 , pp. 33-36
    • Stewart, S.1    Harrington, K.J.2
  • 14
    • 0034065024 scopus 로고    scopus 로고
    • High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas-rationale for combination with radiotherapy
    • Koukourakis M.I., Koukouraki S., Giatromanolaki A., et al. High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas-rationale for combination with radiotherapy. Acta Oncol 39 (2000) 207-211
    • (2000) Acta Oncol , vol.39 , pp. 207-211
    • Koukourakis, M.I.1    Koukouraki, S.2    Giatromanolaki, A.3
  • 15
    • 0032700799 scopus 로고    scopus 로고
    • Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer
    • Koukourakis M.I., Koukouraki S., Giatromanolaki A., et al. Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer. J Clin Oncol 17 (1999) 3512-3521
    • (1999) J Clin Oncol , vol.17 , pp. 3512-3521
    • Koukourakis, M.I.1    Koukouraki, S.2    Giatromanolaki, A.3
  • 16
    • 0028708636 scopus 로고
    • LQ-based model for biological radiotherapy planning
    • Koukourakis M.I., and Damilakis J. LQ-based model for biological radiotherapy planning. Med Dosim 19 (1994) 269-277
    • (1994) Med Dosim , vol.19 , pp. 269-277
    • Koukourakis, M.I.1    Damilakis, J.2
  • 17
    • 33745552177 scopus 로고    scopus 로고
    • Individualization of the subcutaneous amifostine dose during hypofractionated/accelerated radiotherapy
    • Koukourakis M.I., Abatzoglou I., Sivridis L., et al. Individualization of the subcutaneous amifostine dose during hypofractionated/accelerated radiotherapy. Anticancer Res 26 (2006) 2437-2443
    • (2006) Anticancer Res , vol.26 , pp. 2437-2443
    • Koukourakis, M.I.1    Abatzoglou, I.2    Sivridis, L.3
  • 18
    • 4444367495 scopus 로고    scopus 로고
    • Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP)
    • Boccia R., Anne P.R., Bourhis J., et al. Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP). Int J Radiat Oncol Biol Phys 60 (2004) 302-309
    • (2004) Int J Radiat Oncol Biol Phys , vol.60 , pp. 302-309
    • Boccia, R.1    Anne, P.R.2    Bourhis, J.3
  • 19
    • 18544409287 scopus 로고    scopus 로고
    • Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
    • Fu K.K., Pajak T.F., Trotti A., et al. Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
    • (2000) Int J Radiat Oncol Biol Phys , vol.48 , pp. 7-16
    • Fu, K.K.1    Pajak, T.F.2    Trotti, A.3
  • 20
    • 0030737527 scopus 로고    scopus 로고
    • Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomized multicentre trial
    • CHART Steering Committee
    • Saunders M., Dische S., Barrett A., et al., CHART Steering Committee. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomized multicentre trial. Lancet 350 (1997) 161-165
    • (1997) Lancet , vol.350 , pp. 161-165
    • Saunders, M.1    Dische, S.2    Barrett, A.3
  • 21
    • 0035924216 scopus 로고    scopus 로고
    • Invasive bladder carcinoma: a pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatin
    • Zouhair A., Ozsahin M., Schneider D., et al. Invasive bladder carcinoma: a pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatin. Int J Cancer 96 (2001) 350-355
    • (2001) Int J Cancer , vol.96 , pp. 350-355
    • Zouhair, A.1    Ozsahin, M.2    Schneider, D.3
  • 22
    • 0029851252 scopus 로고    scopus 로고
    • Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation
    • National Cancer Institute of Canada Clinical Trials Group
    • Coppin C.M., Gospodarowicz M.K., James K., et al., National Cancer Institute of Canada Clinical Trials Group. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. J Clin Oncol 14 (1996) 2901-2907
    • (1996) J Clin Oncol , vol.14 , pp. 2901-2907
    • Coppin, C.M.1    Gospodarowicz, M.K.2    James, K.3
  • 24
    • 0034192172 scopus 로고    scopus 로고
    • A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of Medical Research Council Trial BA09
    • Duchesne G.M., Bolger J.J., Griffiths G.O., et al. A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of Medical Research Council Trial BA09. Int J Radiat Oncol Biol Phys 47 (2000) 379-388
    • (2000) Int J Radiat Oncol Biol Phys , vol.47 , pp. 379-388
    • Duchesne, G.M.1    Bolger, J.J.2    Griffiths, G.O.3
  • 25
    • 0030910421 scopus 로고    scopus 로고
    • Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly
    • McLaren D.B., Morrey D., and Mason M.D. Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly. Radiother Oncol 43 (1997) 171-174
    • (1997) Radiother Oncol , vol.43 , pp. 171-174
    • McLaren, D.B.1    Morrey, D.2    Mason, M.D.3
  • 26
    • 10044227869 scopus 로고    scopus 로고
    • Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy
    • Cowan R.A., McBain C.A., Ryder W.D., et al. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. Int J Radiat Oncol Biol Phys 59 (2004) 197-207
    • (2004) Int J Radiat Oncol Biol Phys , vol.59 , pp. 197-207
    • Cowan, R.A.1    McBain, C.A.2    Ryder, W.D.3
  • 27
    • 0037710386 scopus 로고    scopus 로고
    • Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial
    • Oncology Hellenic Group
    • Athanassiou H., Antonadou D., Coliarakis N., et al., Oncology Hellenic Group. Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial. Int J Radiat Oncol Biol Phys 56 (2003) 1154-1160
    • (2003) Int J Radiat Oncol Biol Phys , vol.56 , pp. 1154-1160
    • Athanassiou, H.1    Antonadou, D.2    Coliarakis, N.3
  • 28
    • 23044501890 scopus 로고    scopus 로고
    • Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer
    • von der Maase H., Sengelov L., Roberts J.T., et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 23 (2005) 4602-4608
    • (2005) J Clin Oncol , vol.23 , pp. 4602-4608
    • von der Maase, H.1    Sengelov, L.2    Roberts, J.T.3
  • 29
    • 0035887279 scopus 로고    scopus 로고
    • Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC
    • Millikan R., Dinney C., Swanson D., et al. Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol 19 (2001) 4005-4013
    • (2001) J Clin Oncol , vol.19 , pp. 4005-4013
    • Millikan, R.1    Dinney, C.2    Swanson, D.3
  • 30
    • 0142089886 scopus 로고    scopus 로고
    • Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract
    • Winquist E., Ernst D.S., Jonker D., et al. Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract. Eur J Cancer 39 (2003) 1866-1871
    • (2003) Eur J Cancer , vol.39 , pp. 1866-1871
    • Winquist, E.1    Ernst, D.S.2    Jonker, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.